Open AccessBevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement
Author(s) -
Pratima Dibba,
Emmy Ludwig,
Delia Calo,
Hans Gerdes,
Arnold J. Markowitz,
Moshe Shike,
Mark Schattner,
Robin B. Mendelsohn
Publication year - 2020
Publication title -
surgical endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.457
H-Index - 152
eISSN - 1432-2218
pISSN - 0930-2794
DOI - 10.1007/s00464-020-07738-7
Subject(s) - medicine , bevacizumab , percutaneous endoscopic gastrostomy , surgery , perforation , endoscopy , esophageal cancer , cancer , chemotherapy , peg ratio , punching , materials science , finance , economics , metallurgy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom